Clinical Trials
3 trialsNCT00820768 2018-04-11
A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies
Celgene
Phase 1 Withdrawn
NCT00969917 2015-04-14
Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
Infinity Pharmaceuticals, Inc.
Phase 2 Withdrawn
NCT00627627 2010-02-03
A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer
MedImmune LLC
Phase 1/2 Withdrawn